Philipp Baumann

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

Ralf Schmidmaier, Philipp Baumann, Meral Şimşek et al. · Blood · 2004 · 118 citations · Full text

Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial

Gurli Baer, Philipp Baumann, Michael Buettcher et al. · PLoS ONE · 2013 · 111 citations · Full text

Characterizing the connectome in schizophrenia with diffusion spectrum imaging

Alessandra Griffa, Philipp Baumann, Carina Ferrari et al. · Human Brain Mapping · 2014 · 88 citations · Full text

Brain Mapping, Brain Organization, Social Sciences +18

The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells

Sonja Mandl–Weber, Felix G. Meinel, R. Jankowsky et al. · British Journal of Haematology · 2010 · 81 citations · Full text

Hematological Malignancy, Tumor Biology, Novel Inhibitor +14

First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma

Ralf Schmidmaier, Philipp Baumann, Irmgard Bumeder et al. · European Journal Of Haematology · 2007 · 70 citations